jRCT ロゴ

臨床研究等提出・公開システム

Top

Japanese

April. 14, 2026

Sept. 10, 2026

jRCT2052260022

N/A (N/A)

N/A

Koichiro Kinugawa

Toyama University Hospital

2630 Sugitani,Toyama-shi,Toyama,Japan

+81-76-434-2315

kinugawa0422@gmail.com

Okamoto Etsuro

Abbott Medical Japan

1-5-2 Higashi Shimbashi, Minato

+81-76-434-2315

etsuro.okamoto@abbott.com

Not Recruiting

Mar. 02, 2026

Mar. 02, 2026
250

Interventional

single arm study

open(masking not used)

uncontrolled control

single assignment

treatment purpose

1)The patient must be eligible to receive the TriClip System per the current approved indications for use, and
2)The patient must provide written informed consent prior to conducting any investigation-specific procedures not considered standard of care. If informed consent is not obtained, the subject is excluded from the post-approval study (recruitment failure).

NA

No limit
No limit

Both

symptomatic severe tricuspid regurgitation

Interventional tricuspid valve repair

TR

TriClip

D014262

(1) Moderate or less TR at 30-day visit.
(2) Single leaflet device attachment (SLDA) at 30-day visit.

NA

Abbott Medical Japan
Abbott Medical Japan
The National Cardiovascular Research Center IRB
6-1 Shinmachi Kishibe, Suita, Osaka, Osaka

+81-570-012-545

Dec. 22, 2025

No

None

History of Changes

No Publication date
2 Sept. 10, 2026 (this page) Changes
1 April. 14, 2026 Detail